Shannon Thyme Klinger - Jun 7, 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Legal Officer
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
Jun 7, 2021
Transactions value $
$0
Form type
4
Date filed
6/9/2021, 04:10 PM
Previous filing
Jun 9, 2021
Next filing
Jun 22, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Award $0 +42.2K $0.00 42.2K Jun 7, 2021 Common Stock 42.2K $219.57 Direct F1
transaction MRNA Restricted Stock Units Award $0 +18.2K $0.00 18.2K Jun 7, 2021 Common Stock 18.2K $0.00 Direct F2
transaction MRNA Restricted Stock Units Award $0 +9.11K $0.00 9.11K Jun 7, 2021 Common Stock 9.11K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option will vest and become exercisable on June 7, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F2 25% of the shares subject to this restricted stock unit award will vest on June 7, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F3 The shares subject to this restricted stock unit award will vest in full on June 7, 2024, subject to the recipient's continued service.